BamSEC and AlphaSense Join Forces
Learn More

iBio Inc.

NYSE American: IBIO    
Share price (1/6/25): $2.46    
Market cap (1/6/25): $22.5 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 31 pages Certain Confidential Information Contained in This Exhibit Marked by [***] Has Been Omitted Because It Is Both Not Material and Is the Type of Information That the Registrant Treats as Private or Confidential Exclusive License Agreement
12/34/56
EX-10
from 8-K 13 pages Amended and Restated Employment Agreement
12/34/56
EX-10.7
from 8-K 12 pages IBIO, Inc. Incentive Stock Option Agreement for Officers Under the IBIO, Inc. 2023 Omnibus Incentive Plan
12/34/56
EX-10.6
from 8-K 12 pages IBIO, Inc. Incentive Stock Option Agreement for Employees Under the IBIO, Inc. 2023 Omnibus Incentive Plan
12/34/56
EX-10.5
from 8-K 8 pages IBIO, Inc. Restricted Stock Unit Award Agreement for Employees Under the IBIO, Inc. 2023 Omnibus Incentive Plan
12/34/56
EX-10.4
from 8-K 12 pages IBIO, Inc. Non-Qualified Stock Option Agreement for Employees Under the IBIO, Inc. 2023 Omnibus Incentive Plan
12/34/56
EX-10.3
from 8-K 9 pages For Directors (Annual Grant) IBIO, Inc. Non-Qualified Stock Option Agreement for Non-Employee Directors Under the IBIO, Inc. 2023 Omnibus Incentive Plan
12/34/56
EX-10.2
from 8-K 9 pages For Non-Employee Consultants Natural Person/Non-Capital Raising Only IBIO, Inc. Non-Qualified Stock Option Agreement for Non-Employee Consultants Under the IBIO, Inc. 2023 Omnibus Incentive Plan ​
12/34/56
EX-10.1
from 8-K 8 pages IBIO, Inc. Non-Qualified Stock Option Agreement for Non-Employee Directors Under the IBIO, Inc. 2023 Omnibus Incentive Plan
12/34/56
EX-10.2
from 8-K 67 pages Settlement Agreement and Mutual Release
12/34/56
EX-10.1
from 8-K 39 pages Purchase and Sale Agreement
12/34/56
EX-10.9
from 10-Q 16 pages IBIO, Inc. Officer Severance Benefit Plan
12/34/56
EX-10.2
from 8-K 7 pages Director Agreement
12/34/56
EX-10.1
from 8-K 44 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 59 pages ​ Asset Purchase Agreement ​ by and Between ​ IBIO, Inc. ​ and ​ Otsuka Pharmaceutical Co., Ltd. ​ Dated as of February 25, 2024 ​
12/34/56
EX-10.4
from 8-K 2 pages Date: January 16, 2024 Loeb Term Solutions LLC (“Lts”) 8609 W. Bryn Mawr, Suite 208 Chicago, Il 60631 ​ Re: IBIO, Inc., a Delaware Corporation (The “Debtor”) ​ Ladies and Gentlemen: ​
12/34/56
EX-10.3
from 8-K 3 pages Term Promissory Note
12/34/56
EX-10.1
from 8-K 39 pages Securities Purchase Agreement
12/34/56
EX-10.59
from S-1/A 37 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 13 pages IBIO, Inc. 2023 Omnibus Incentive Plan
12/34/56